All News

    The Variability of Data and Importance of Personalized Lung Cancer Care

    August 14th 2025, 4:00pm

    Article

    Dr. Jacob Sands explained that he believes patients should be having more personalized, nuanced conversations with their oncologists.

    Real-World Data on Treatment Outcomes in HER2-Negative Breast Cancer

    August 14th 2025, 3:00pm

    Article

    Real-world data show that Enhertu benefits those with HR+ breast cancer, whereas Trodelvy is effective as an initial treatment for HER2-null/HER2– disease.

    How Patients with Kidney Cancer Can Get Up-to-Date, Timely Information

    August 14th 2025, 1:00pm

    Video

    There are many reliable resources available to patients with kidney cancer, as well as their families and caregivers.

    Off-The-Shelf Vaccine Elicits Durable Responses in Pancreatic, Colorectal Cancers

    August 13th 2025, 9:00pm

    Article

    Dr. Zev Wainberg of UCLA recently spoke with CURE about trial results concerning the cancer vaccine ELI-002 2P.

    Survivor Shares How Acupuncture and Nutrition Supported Treatment

    August 13th 2025, 8:00pm

    Video

    Follicular lymphoma survivor Troy Anderson credited acupuncture and nutrition guidance with easing treatment side effects and aided in remission.

    New Treatment Combo Shows Benefit for Patients with GIST

    August 13th 2025, 7:00pm

    Article

    Among patients with advanced gastrointestinal stromal tumors, Gleevec and Mektovi was associated with benefits in progression and survival.

    Healing, Hope and the Power of Advocacy

    August 13th 2025, 5:00pm

    Article

    When I was diagnosed with peritoneal mesothelioma at 21 years old, the doctors gave me 18 months to live; that was 18 years ago.

    Not All Prostate Cancer Follows a Slow-Growing Course

    August 13th 2025, 4:00pm

    Article

    About one in six men with grade group 1 prostate cancer have higher-risk disease, showing outcomes vary and biopsy grade may underestimate risk.

    Keytruda and Padcev Generate Positive Topline Findings in Bladder Cancer

    August 13th 2025, 3:00pm

    Article

    Keytruda and Padcev generated promising topline results for those with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy.

    When Rusfertide May Become Accessible for Those with Polycythemia Vera

    August 13th 2025, 1:00pm

    Video

    Dr. Aaron Gerds explained when treatment with rusfertide will become accessible for patients with a myeloproliferative neoplasm like polycythemia vera.